Anebulo Pharmaceuticals ratios data for the quarter ended Dec 2025. These financial ratios cover 23 quarters of results from Jun 2020 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Efficiency | |||||||||||||||||||||||
| Assets AverageAssets Avg. | 12.97M | 21.08M | 19.73M | 18.11M | 16.41M | 17.70M | 18.35M | 15.66M | 13.05M | 10.36M | 8.27M | 6.75M | 5.03M | 3.27M | 9.15M | 14.92M | 13.08M | 11.42M | 10.06M | ||||
| Equity AverageEquity Avg. | -5.08M | 5.99M | 20.65M | 19.40M | 18.04M | 16.11M | 17.09M | 17.32M | 14.23M | 11.77M | 9.47M | 7.41M | 5.74M | 4.40M | 2.86M | 8.43M | 14.21M | 12.56M | 10.70M | 8.84M | |||
| Invested CapitalInvested Cap. | |||||||||||||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -149.18 | -86.70 | -27.88 | -12.36 | -24.12 | -25.88 | -7.72 | -65.80 | -129.61 | -150.23 | |||||||||||||
| Debt Ratio | |||||||||||||||||||||||
| Times Interest Earned | -149.18 | -86.70 | -27.88 | -12.36 | -24.12 | -25.88 | -7.72 | -65.80 | -129.61 | -150.23 | |||||||||||||
| Valuation | |||||||||||||||||||||||
| Price to BookP/B | 4.34 | 7.69 | 7.59 | 9.63 | 8.06 | 3.75 | 4.00 | 5.74 | 5.68 | 9.41 | 9.67 | 14.93 | 18.57 | 26.36 | 3.08 | 3.97 | 4.18 | 10.55 | 5.23 | ||||
| Enterprise Value | 72.85M | 133.70M | 125.56M | 148.73M | 106.84M | 52.56M | 45.68M | 60.17M | 48.99M | 69.92M | 56.11M | 69.28M | 67.70M | 48.65M | 31.06M | 40.13M | 37.07M | 92.36M | 32.45M | ||||
| Market Capitalization | 92.84M | 152.91M | 143.57M | 165.28M | 121.39M | 71.77M | 62.03M | 74.34M | 60.24M | 78.44M | 62.76M | 74.43M | 70.80M | 50.05M | 46.06M | 53.41M | 48.70M | 102.71M | 41.50M | ||||
| Return Ratios | |||||||||||||||||||||||
| Return on Assets [ROA]ROA | -27.79% | -23.29% | -28.66% | -38.54% | -41.62% | -44.57% | -57.88% | -73.60% | -89.61% | -111.71% | -126.71% | -138.64% | -164.07% | -252.48% | -89.81% | -57.63% | -72.23% | -79.91% | -89.44% | ||||
| Return on Equity [ROE]ROE | -60.22% | -23.77% | -29.14% | -38.69% | -42.39% | -46.15% | -61.34% | -81.01% | -99.36% | -122.24% | -141.51% | -163.09% | -187.77% | -289.16% | -97.52% | -60.52% | -75.21% | -85.33% | -101.84% |
Pull Anebulo Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=ANEB&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "ANEB", "statement": "Ratios", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=ANEB&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();